Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that retain or improve the antioxidant properties of capsaicin. Crystal structures of their complexes with AChE and BChE revealed the molecular basis for their high potency. Brain penetration was confirmed by biodistribution studies in C57BL6 mice, with one compound ( 5i ) displaying better brain/plasma ratio than donepezil. Chronic treatment of 10 month-old APP/PS1 mice with 5i (2 mg/kg, i.p., 3 times per week, 4 weeks) rescued learning and memory impairments, as measured by three different behavioral tests, delayed the Alzheimer-like pathology progression, as suggested by a significantly reduced Aβ42/Aβ40 ratio in the hippocampus, improved basal synaptic efficacy, and significantly reduced hippocampal oxidative stress and neuroinflammation. Compound 5i emerges as an interesting anti-Alzheimer lead with beneficial effects on cognitive symptoms and on some underlying disease mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Use of a Free Radical Method to Evaluate Antioxidant Activity
Brand-Williams, W., Cuvelier, M. E., & Berset, C. (1995) · LWT - Food Science and Technology · doi:10.1016/s0023-6438(95)80008-5 · Cited by 25,994
The Chemistry behind Antioxidant Capacity Assays
Huang, D., Ou, B., & Prior, R. L. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030723c · Cited by 6,162
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
The open-field test: A critical review.
WALSH, R. N., & Cummins, R. A. (1976) · Psychological Bulletin · doi:10.1037//0033-2909.83.3.482 · Cited by 2,506
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Bevins, R. A., & Besheer, J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.205 · Cited by 1,277
High throughput artificial membrane permeability assay for blood–brain barrier
Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,101
Self-citationCornish-Bowden, A. (1974) · Biochemical Journal · doi:10.1042/bj1370143 · Cited by 935
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., et al. (2000) · Nature · doi:10.1038/35050103 · Cited by 740
Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508575102 · Cited by 734
Prevention of Undesirable Isomerization during Olefin Metathesis
Hong, S. H., Sanders, D. P., Lee, C. W., & Grubbs, R. H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052939w · Cited by 648
Nachon, F., Carletti, E., Ronco, C., Trovaslet, M., Nicolet, Y., Jean, L., & Renard, P.-Y. (2013) · Biochemical Journal · doi:10.1042/bj20130013 · Cited by 478
Self-citationOrganic Chemistry of Enzyme-Catalyzed Reactions
(2002) · Elsevier eBooks · doi:10.1016/c2009-0-22837-6 · Cited by 380
Reassessing the amyloid cascade hypothesis of Alzheimer's disease
Pimplikar, S. W. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.015 · Cited by 375
Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice
Trinchese, F., Liu, S., Battaglia, F., Walter, S., Mathews, P. M., & Arancio, O. (2004) · Annals of Neurology · doi:10.1002/ana.20101 · Cited by 373
Taylor, P., & Lappi, S. (1975) · Biochemistry · doi:10.1021/bi00680a029 · Cited by 364
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease
Nordberg, A., Ballard, C., Bullock, R., Darreh-Shori, T., & Somogyi, M. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01412 · Cited by 323
Alvarez, A., Alarcón, R., Opazo, C., Campos, E. O., Muñoz, F. J., Calderón, F. H., Dajas, F., Gentry, M. K., Doctor, B. P., De Mello, F. G., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03213.1998 · Cited by 317
Self-citationAlvarez, A., Opazo, C., Alarcón, R., Garrido, J., & Inestrosa, N. C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1245 · Cited by 306
Self-citationDrugs in Clinical Trials for Alzheimer's Disease: The Major Trends
Bachurin, S. O., Bovina, E. V., & Ustyugov, A. A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21434 · Cited by 304
Rosenberry, T. L., Brazzolotto, X., Macdonald, I. R., Wandhammer, M., Trovaslet-Leroy, M., Darvesh, S., & Nachon, F. (2017) · Molecules · doi:10.3390/molecules22122098 · Cited by 298
Self-citationBrus, B., Košak, U., Turk, S., Pišlar, A., Coquelle, N., Kos, J., Stojan, J., Colletier, J.-P., & Gobec, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501195e · Cited by 285
Self-citationKamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E.-J., Moeton, M., Freriks, M., Mizee, M. R., & Hol, E. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.035 · Cited by 269
Fernández-Bachiller, M. I., Pérez, C., Monjas, L., Rademann, J., & Rodríguez-Franco, M. I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201460y · Cited by 268
Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229
The synaptic Aβ hypothesis of Alzheimer disease
Tanzi, R. E. (2005) · Nature Neuroscience · doi:10.1038/nn0805-977 · Cited by 206
Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?: Miniperspective
Rosini, M., Simoni, E., Milelli, A., Minarini, A., & Melchiorre, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400970m · Cited by 201
Camps, P., El Achab, R., Morral, J., Muñoz-Torrero, D., Badia, A., Baños, J. E., Vivas, N. M., Barril, X., Orozco, M., & Luque, F. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000980y · Cited by 201
Self-citationCapsaicin—the major bioactive ingredient of chili peppers: bio-efficacy and delivery systems
Lu, M., Chen, C., Lan, Y., Xiao, J., Li, R., Huang, J., Huang, Q., Cao, Y., & Ho, C.-T. (2020) · Food & Function · doi:10.1039/d0fo00351d · Cited by 179
Gontijo, V. S., Viegas, F. P. D., Ortiz, C. J. C., Silva, M. D. F., Damásio, C. M., Rosa, M. C., Campos, T. G., Couto, D. S., Dias, K. S. T., & Viegas, C. (2019) · Current Neuropharmacology · doi:10.2174/1385272823666191021124443 · Cited by 160
Fernández‐Bachiller, M. I., Pérez, C., Campillo, N. E., Páez, J. A., González‐Muñoz, G. C., Usán, P., García‐Palomero, E., López, M. G., Villarroya, M., García, A. G., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200800414 · Cited by 159
Dairam, A., Fogel, R., Daya, S., & Limson, J. L. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0734931 · Cited by 159
Viayna, E., Sola, I., Bartolini, M., De Simone, A., Tapia-Rojas, C., Serrano, F. G., Sabaté, R., Juárez-Jiménez, J., Pérez, B., Luque, F. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401824w · Cited by 154
Self-citationVargas, J. Y., Fuenzalida, M., & Inestrosa, N. C. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0862-13.2014 · Cited by 148
Self-citationThe Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
Deardorff, W. J., Feen, E. S., & Grossberg, G. T. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0273-x · Cited by 147
Savini, L., Gaeta, A., Fattorusso, C., Catalanotti, B., Campiani, G., Chiasserini, L., Pellerano, C., Novellino, E., McKissic, D., & Saxena, A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0255668 · Cited by 146
Darvesh, S., Cash, M. K., Reid, G. A., Martin, E., Mitnitski, A., & Geula, C. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823cc7a6 · Cited by 145
Nepovimova, E., Korabecny, J., Dolezal, R., Babkova, K., Ondrejicek, A., Jun, D., Sepsova, V., Horova, A., Hrabinova, M., Soukup, O., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01325 · Cited by 128
Garrido, J. M. P. J., Gaspar, A., Garrido, E. M., Miri, R., Tavakkoli, M., Pourali, S., Saso, L., Borges, F., & Firuzi, O. (2011) · Biochimie · doi:10.1016/j.biochi.2011.12.015 · Cited by 127
Self-citationBrazzolotto, X., Wandhammer, M., Ronco, C., Trovaslet, M., Jean, L., Lockridge, O., Renard, P., & Nachon, F. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08672.x · Cited by 126
Self-citationDvir, H., Wong, D. M., Harel, M., Barril, X., Orozco, M., Luque, F. J., Muñoz-Torrero, D., Camps, P., Rosenberry, T. L., Silman, I., et al. (2002) · Biochemistry · doi:10.1021/bi011652i · Cited by 125
Self-citationAndrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice
Serrano, F. G., Tapia-Rojas, C., Carvajal, F. J., Hancke, J., Cerpa, W., & Inestrosa, N. C. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-61 · Cited by 116
Self-citationGreenblatt, H. M., Dvir, H., Silman, I., & Sussman, J. L. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:369 · Cited by 112
Self-citationLi, Q., Xing, S., Chen, Y., Liao, Q., Xiong, B., He, S., Lu, W., Liu, Y., Yang, H., Li, Q., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01129 · Cited by 111
Camps, P., Cusack, B. M., Mallender, W. D., Achab, R. E., Morral, J., Muñoz‐Torrero, D., & Rosenberry, T. L. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23214-4 · Cited by 109
Self-citationTargeting Synaptic Plasticity in Experimental Models of Alzheimer’s Disease
Mango, D., Saidi, A., Cisale, G. Y., Feligioni, M., Corbo, M., & Nisticò, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00778 · Cited by 107
Sussman, J. L., Harel, M., Frolow, F., Varon, L. E., Toker, L., Futerman, A. H., & Silman, I. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90213-6 · Cited by 106
Self-citationRelationship between plaques, tangles, and loss of cortical cholinergic fibers in alzheimer disease
Geula, C., Mesulam, M. M., Saroff, D. M., & Wu, C.-K. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199801000-00008 · Cited by 102
Rodrigues, R., Petersen, R. B., & Perry, G. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0074-5 · Cited by 99
Galdeano, C., Viayna, E., Sola, I., Formosa, X., Camps, P., Badia, A., Clos, M. V., Relat, J., Ratia, M., Bartolini, M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm200840c · Cited by 95
Self-citationDu, Y., Fu, M., Huang, Z., Tian, X., Li, J., Pang, Y., Song, W., Tian Wang, Y., & Dong, Z. (2020) · Aging Cell · doi:10.1111/acel.13113 · Cited by 95
Wang, T., Liu, X.-H., Guan, J., Ge, S., Wu, M.-B., Lin, J.-P., & Yang, L.-R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.076 · Cited by 93
Rivera, D. S., Lindsay, C. B., Codocedo, J. F., Morel-Letelier, I., Pinto, C., Cisternas, P., Bozinovic, F., & Inestrosa, N. C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.021 · Cited by 89
Self-citationThe chemistry toolbox of multitarget-directed ligands for Alzheimer's disease
Mesiti, F., Chavarria, D., Gaspar, A., Alcaro, S., & Borges, F. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111572 · Cited by 72
Jiang, X., Jia, L.-W., Li, X.-H., Cheng, X.-S., Xie, J.-Z., Ma, Z.-W., Xu, W.-J., Liu, Y., Yao, Y., Du, L.-L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121837 · Cited by 70
Knez, D., Brus, B., Coquelle, N., Sosič, I., Šink, R., Brazzolotto, X., Mravljak, J., Colletier, J., & Gobec, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.010 · Cited by 62
Self-citationViayna, E., Gómez, T., Galdeano, C., Ramírez, L., Ratia, M., Badia, A., Clos, M. V., Verdaguer, E., Junyent, F., Camins, A., et al. (2010) · ChemMedChem · doi:10.1002/cmdc.201000322 · Cited by 60
Self-citationReactive oxygen species: friend or foe?
Sharma, A. K., Taneja, G., Khanna, D., & Rajput, S. K. (2015) · RSC Advances · doi:10.1039/c5ra07927f · Cited by 59
Elsinghorst, P. W., Cieslik, J. S., Mohr, K., Tränkle, C., & Gütschow, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070859s · Cited by 55
Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in Mice
Chen, L., Huang, Z., Du, Y., Fu, M., Han, H., Wang, Y., & Dong, Z. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170337 · Cited by 54
The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function
Liu, C.-H., Bu, X.-L., Wang, J., Zhang, T., Xiang, Y., Shen, L.-L., Wang, Q.-H., Deng, B., Wang, X., Zhu, C., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151079 · Cited by 52
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51
Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00623 · Cited by 49
Self-citationSalazar, P. L., Cisternas, P., Codocedo, J. F., & Inestrosa, N. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.002 · Cited by 48
Self-citationNovel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
Patel, D. V., Patel, N. R., Kanhed, A. M., Patel, S. P., Sinha, A., Kansara, D. D., Mecwan, A. R., Patel, S. B., Upadhyay, P. N., Patel, K. B., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00226 · Cited by 48
Chaudhary, A., Gour, J. K., & Rizvi, S. I. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1669056 · Cited by 48
Pérez-Areales, F. J., Pietro, O. D., Espargaró, A., Vallverdú‐Queralt, A., Galdeano, C., Ragusa, I. M., Viayna, E., Guillou, C., Clos, M. V., Pérez, B., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.053 · Cited by 47
Self-citationPropidium—a Fluorescence Probe for a Peripheral Anionic Site on Acetylcholinesterase
TAYLOR, P., LWEBUGA-MUKASA, J., LAPPI, S., & RADEMACHER, J. (1974) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13975-8 · Cited by 47
Cisternas, P., Lindsay, C. B., Salazar, P. L., Silva-Álvarez, C., Retamales-Ortega, R., Serrano, F. G., Vio, C. P., & Inestrosa, N. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.009 · Cited by 46
Self-citationCisternas, P., Oliva, C. A., Torres, V. I., Barrera, D. P., & Inestrosa, N. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00295 · Cited by 45
Self-citationMalek, R., Arribas, R. L., Palomino-Antolin, A., Totoson, P., Demougeot, C., Kobrlova, T., Soukup, O., Iriepa, I., Moraleda, I., Diez-Iriepa, D., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00937 · Cited by 45
Yang, Z., Song, Q., Cao, Z., Yu, G., Liu, Z., Tan, Z., & Deng, Y. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115374 · Cited by 45
Ronco, C., Foucault, R., Gillon, É., Bohn, P., Nachon, F., Jean, L., & Renard, P. (2011) · ChemMedChem · doi:10.1002/cmdc.201000523 · Cited by 44
Self-citationRonco, C., Carletti, E., Colletier, J., Weik, M., Nachon, F., Jean, L., & Renard, P. (2011) · ChemMedChem · doi:10.1002/cmdc.201100438 · Cited by 43
Self-citationCharacterisation of the anticholinesterase activity of two new tacrine–huperzine A hybrids
Alcalá, M. D. M., Vivas, N. M., Camps, P., Muñoz‐Torrero, D., & Badı́a, A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00071-6 · Cited by 43
Self-citationLalut, J., Payan, H., Davis, A., Lecoutey, C., Legay, R., Santos, J. S. O., Claeysen, S., Dallemagne, P., & Rochais, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-59805-7 · Cited by 43
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
Pérez-Areales, F. J., Garrido, M., Aso, E., Bartolini, M., Simone, A. D., Espargaró, A., Ginex, T., Sabaté, R., Pérez, B., Andrisano, V., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00528 · Cited by 43
Self-citationEstrada, M., Herrera‐Arozamena, C., Pérez, C., Viña, D., Morales-Garcia, J. A., Pérez‐Castillo, A., Ramos, E., Romero, A., Laurini, E., Pricl, S., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1581184 · Cited by 41
Xie, Z., Liao, Q., Xu, X., Yao, M., Wan, J., & Liu, D. (2006) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2718 · Cited by 39
Pérez-Areales, F. J., Turcu, A. L., Barniol-Xicota, M., Pont, C., Pivetta, D., Espargaró, A., Bartolini, M., De Simone, A., Andrisano, V., Pérez, B., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.051 · Cited by 38
Self-citationInhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants
Nunes‐Tavares, N., da Matta, A. N., Silva, C. M. B. E., Araújo, G. M. N., Louro, S. R. W., & HASSÓN-VOLOCH, A. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00027-4 · Cited by 37
Bioactive Compounds in Kimchi Improve the Cognitive and Memory Functions Impaired by Amyloid Beta
Woo, M., Kim, M. J., & Song, Y. O. (2018) · Nutrients · doi:10.3390/nu10101554 · Cited by 35
Xu, A., He, F., Zhang, X., Li, X., Ran, Y., Wei, C., James Chou, C., Zhang, R., & Wu, J. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103721 · Cited by 34
Novel Coumarin‐Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
Duarte, Y., Fonseca, A., Gutiérrez, M., Adasme‐Carreño, F., Muñoz‐Gutierrez, C., Alzate‐Morales, J. H., Santana, L., Uriarte, E., Álvarez, R., & Matos, M. J. (2019) · ChemistrySelect · doi:10.1002/slct.201803222 · Cited by 32
Wu, M., Ma, J., Ji, L., Wang, M., Han, J., & Li, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.055 · Cited by 32
Acetylcholinesterase Protein Level Is Preserved in the Alzheimer's Brain
Campanari, M., García‐Ayllón, M., Blázquez‐Llorca, L., Luk, W. K. W., Tsim, K. W. K., & Sáez‐Valero, J. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0183-5 · Cited by 30
Gabr, M. T., & Brogi, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00756 · Cited by 30
Woo, M., Noh, J. S., Cho, E. J., & Song, Y. O. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01686 · Cited by 27
Huprines for Alzheimer's disease drug development
Muñoz‐Torrero, D., & Camps, P. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.1.65 · Cited by 25
Self-citationStructure-Based Survey of the Binding Modes of BACE1 Inhibitors
Hu, H., Chen, Z., Xu, X., & Xu, Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00420 · Cited by 25
Pietro, O. D., Juárez‐Jiménez, J., Muñoz‐Torrero, D., Laughton, C. A., & Luque, F. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177683 · Cited by 24
Self-citationIn vitro photo-release of a TRPV1 agonist
Carr, J. L., Wease, K. N., Ryssen, M. P. V., Paterson, S., Agate, B., Gallagher, K. A., Brown, C. T. A., Scott, R. H., & Conway, S. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.018 · Cited by 21
Zhang, J., Yu, L., Yang, H., Hui, Z., Jiang, S., Chen, L., Zhao, Y., Wang, S., Liu, Y., & Xu, Y. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2237-2 · Cited by 18
Barraza-Garza, G., Pérez-León, J. A., Castillo-Michel, H. A., la Rosa, L. A. D., Martı́nez-Martı́nez, A., Cotte, M., & Alvarez-Parrilla, E. (2019) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2019.117570 · Cited by 17
Evaluation of a new lead for acetylcholinesterase inhibition
Khorana, N., Markmee, S., Ingkaninan, K., Ruchirawat, S., Kitbunnadaj, R., & Pullagurla, M. R. (2008) · Medicinal Chemistry Research · doi:10.1007/s00044-008-9122-3 · Cited by 15
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists
Cole, A. G., Metzger, A., Brescia, M., Qin, L.-Y., Appell, K. C., Brain, C. T., Hallett, A., Ganju, P., Denholm, A. A., Wareing, J. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.005 · Cited by 11
Improved Access to Huprine Derivatives Functionalized at Position 9
Oukoloff, K., Chao, S., Cieslikiewicz‐Bouet, M., Mougeot, R., Jean, L., & Renard, P. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201501433 · Cited by 7
Self-citationYancheva, D. Y., Stoyanov, S., Anichina, K., Nikolova, S., Velcheva, E. A., & Stamboliyska, B. A. (2020) · Chemical Physics · doi:10.1016/j.chemphys.2020.110763 · Cited by 5
Research works printed but not linked: 3
- Camps P., 2000, Mol. Pharmacol., 57, 409
- Taylor P., 1974, Mol. Pharmacol., 10, 703
- 10.1037/0033-2909.83.3.482 · doi:10.1037/0033-2909.83.3.482 · Paper page
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“530 Given the elevated activity of monoamine oxidase-B (MAO-B) observed in AD, dual inhibition of AChE and MAO-B holds promise for synergistic effects on cholinergic system recovery and A β plaque formation, along with potential bene fi ts in alleviating oxidative stress injury.”
BackgroundSustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease
Rossi, M., Freschi, M., Nascente, L. D. C., Salerno, A., Teixeira, S. D. M. V., Nachon, F., Chantegreil, F., Soukup, O., Prchal, L., Malaguti, M., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00048 · Cited by 147
Self-citationCodony, S., Pont, C., Griñán‐Ferré, C., Pede-Mattatelli, A. D., Calvó‐Tusell, C., Feixas, F., Osuna, S., Jarné‐Ferrer, J., Naldi, M., Bartolini, M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02150 · Cited by 61
Self-citationTacrine-Based Hybrids: Past, Present, and Future
Bubley, A., Erofeev, A. S., Gorelkin, P. V., Beloglazkina, E. K., Majouga, A. G., & Krasnovskaya, O. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021717 · Cited by 53
Click chemistry-aided drug discovery: A retrospective and prospective outlook
Zhao, R., Zhu, J., Jiang, X., & Bai, R. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116037 · Cited by 48
Metadata
- Authors
- Viayna, E., Coquelle, N., Cieslikiewicz-Bouet, M., Cisternas, P., Oliva, C. A., Sánchez-López, E., Ettcheto, M., Bartolini, M., De Simone, A., Ricchini, M., Rendina, M., Pons, M., Firuzi, O., Pérez, B., Saso, L., Andrisano, V., Nachon, F., Brazzolotto, X., García, M. L., Camins, A., Silman, I., Jean, L., Inestrosa, N. C., Colletier, J.-P., Renard, P.-Y., & Muñoz-Torrero, D.
- Affiliations
- Institut de Biomedicina de la Universitat de Barcelona (ES)
- Centre National de la Recherche Scientifique (FR)
- Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France
- Pontificia Universidad Católica de Chile (CL)
- Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain
- Instituto de Salud Carlos III (ES)
- University of Bologna (IT)
- Department of Drug Science and Technology, University of Turin, I-10125 Torino, Italy
- Shiraz University of Medical Sciences (IR)
- Universitat Autònoma de Barcelona (ES)
- Sapienza University of Rome (IT)
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées BP73, 91993 Brétigny sur Orge, France
- Weizmann Institute of Science (IL)
- Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain
- Corresponding author
- Inestrosa, Nibaldo C.
- Colletier, Jacques-Philippe
- Renard, Pierre-Yves
- ORCID
- Viayna, Elisabet
- Coquelle, Nicolas
- Cisternas, Pedro
- Oliva, Carolina A.
- Ettcheto, Miren
- Bartolini, Manuela
- Firuzi, Omidreza
- Pérez, Belén
- Saso, Luciano
- Andrisano, Vincenza
- Nachon, Florian
- Brazzolotto, Xavier
- García, Maria Luisa
- Camins, Antoni
- Silman, Israel
- Jean, Ludovic
- Inestrosa, Nibaldo C.
- Colletier, Jacques-Philippe
- Renard, Pierre-Yves
- Muñoz-Torrero, Diego
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-12-28
- Volume
- 64
- Issue
- 1
- Pages
- 812-839
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3113989042
- Cited by
- 106
- References
- 101
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 21 · 2023: 19 · 2022: 13 · 2021: 9
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-12-BS07-0008-01)
- Ministry of Science, Innovation and Universities (SAF2014-57094-R, SAF2017-82771-R)
- Generalitat de Catalunya (2017SGR106)
- Alzheimer Nadacn?? Fond (FA-AAP-2013-65-101349)
- Fondo Nacional de Desarrollo Cient??fico y Tecnol??gico (11160651)
- MIADES (T010131, T010132)
- Ministero dell'Istruzione, dell'Universit?? e della Ricerca
- Agencia Estatal de Investigaci??n (SAF2014-57094-R, SAF2017-82771-R)
- FEDER (SAF2014-57094-R, SAF2017-82771-R)
- Basal Center of Excellence in Aging and Regeneration (CONICYT-AFB 170005)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pesticide Exposure and Toxicity
- Keywords
- capsaicin, antioxidant activity, Alzheimer's disease, APP/PS1 mice, amyloid-beta 42/40 ratio, neuroinflammation, synaptic efficacy, learning and memory impairment, brain penetration, crystal structure
- MeSH terms
- Acetylcholinesterase, Alzheimer Disease, Amyloid, Animals, Antioxidants, Binding Sites, Brain, Butyrylcholinesterase, Cholinesterase Inhibitors, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Male, Mice, Inbred C57BL, Structure-Activity Relationship, Tissue Distribution, Aspartic Acid Endopeptidases, Oxidative Stress, Mice, Amyloid Precursor Protein Secretases, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.